+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuroendocrine Carcinoma"

Endothelial PAS Domain-containing Protein 1 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Endothelial PAS Domain-containing Protein 1 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025 - Product Thumbnail Image

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Carcinoid Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Carcinoid Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Gastric Neuroendocrine Tumors Pipeline Analysis Report 2025 - Product Thumbnail Image

Gastric Neuroendocrine Tumors Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Neuroendocrine Tumors Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Neuroendocrine Tumors Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Carcinoid Tumor Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Carcinoid Tumor Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Gastric Cancer Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Gastric Cancer Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Somatostatin Analogs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Somatostatin Analogs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • May 2025
  • 82 Pages
  • Global
From
Angiopoietin 1 Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Angiopoietin 1 Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 102 Pages
  • Global
From
Somatostatin Analogs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

Somatostatin Analogs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • April 2025
  • 130 Pages
  • Global
From
Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022 - Product Thumbnail Image

Global Cancer mTOR Inhibitors Market & Clinical Pipeline Outlook 2022

  • Report
  • February 2018
  • 160 Pages
  • Global
From
Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Radioligand Therapy Market - A Global and Regional Analysis: Focus on Indication, Product, Biomarker, and Region - Analysis and Forecast, 2021-2031

  • Report
  • March 2022
  • 182 Pages
  • Global
From
Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Thumbnail Image

Neuroendocrine Tumors (NETs) Market (2024 Edition): Analysis By Therapy (Somatostatin Analogs (SSAs), Targeted Therapy, Others), By Route of Administration, By Indication, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • June 2024
  • 300 Pages
  • Global
From
Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Gastro Esophageal Junction Neuroendocrine Tumor Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Neuroendocrine Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 - Product Thumbnail Image

Radioligand Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

  • Report
  • June 2023
  • 119 Pages
  • Global
From
Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product Analysis, By Site Analysis, By End User, By Region and Competition - Product Thumbnail Image

Neuroendocrine Tumor Treatment Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Product Analysis, By Site Analysis, By End User, By Region and Competition

  • Report
  • March 2023
  • 117 Pages
  • Global
From
Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Gastro-Esophageal Junction Neuroendocrine Tumor (GEJ-NET) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Neuroendocrine Carcinoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Loading Indicator

Neuroendocrine carcinoma (NEC) is a rare type of cancer that affects the neuroendocrine system, which is responsible for the production of hormones. It is a type of cancer that is often difficult to diagnose and treat. Treatment options for NEC include surgery, chemotherapy, radiation therapy, and targeted therapies. Oncology drugs are used to treat NEC, and they can be used alone or in combination with other treatments. These drugs can help to reduce the size of tumors, slow the growth of cancer cells, and reduce the risk of recurrence. The Neuroendocrine Carcinoma market is a rapidly growing segment of the oncology drugs market. It is driven by the increasing prevalence of NEC, the development of new treatments, and the increasing availability of targeted therapies. Companies in the market include Novartis, Pfizer, Merck, AstraZeneca, and Roche. Show Less Read more